Lexicon replaces irritable bowel lead candidate with follow-on compound
12 August 2011
Sukaina Virji
Please Login to read the full article.
12 August 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Salix presents data to expand markets for bowel disorder drugs Xifaxan and Relistor
- Invus pulls the financial levers as Lexicon faces significant spending obligations
- FDA reviewers question proposed study design for Salix's Xifaxan in IBS
- Salix bumps up GI portfolio with Oceana buy for $300m
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
